Skip Navigation
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Division of AIDS Overview

The Division of AIDS (DAIDS) was formed in 1986 to develop and implement the national research agenda to address the HIV/AIDS epidemic. Toward that end, the division supports a global research portfolio to advance biological knowledge of HIV/AIDS, its related co-infections, and co-morbidities. With the ultimate goal of creating an “AIDS-Free Generation,” the division develops and supports the infrastructure and biomedical research needed to: 1) halt the spread of HIV through the development of an effective vaccine and biomedical prevention strategies that are safe and desirable; 2) develop novel approaches for the treatment and cure of HIV infection; 3) treat and/or prevent HIV co-infections and co-morbidities of greatest significance; and 4) partner with scientific and community stakeholders to efficiently implement effective interventions.

Organizationally, DAIDS is comprised of the Office of the Director (OD) and four scientific programs. Within the OD is the: 1) Workforce Operations, Communications, and Reporting Branch; 2) Science Planning and Operations Branch; 3) Office of Clinical Site Oversight, which includes the Pharmaceutical Affairs Branch, Monitoring and Operations Branch, Africa and the Domestic Partners Branch, and Asia and the Americas Branch; and 4) Office for Policy in Clinical Research Operations which includes the Regulatory Affairs Branch, Clinical Research Resources Branch, and the Protection of Participants, Evaluation and Policy Branch.

The four scientific programs include the: 1) Basic Sciences Program, which includes the Pathogenesis and Basic Research Branch, Targeted Interventions Branch, and the Epidemiology Branch; 2) Therapeutics Research Program, which includes the HIV Research Branch, Drug Development and Clinical Sciences Branch, TB Clinical Research Branch, and the Complications and Co-infections Research Branch; 3) Vaccine Research Program, which includes the Preclinical Research and Development Branch, Vaccine Translational Research Branch, and the Vaccine Clinical Research Branch; and 4) Prevention Sciences Program which includes the Preclinical Microbicide and Prevention Research Branch, Clinical Microbicide Research Branch, Clinical Prevention Research Branch, and the Maternal, Adolescent, and Pediatric Research Branch.

 
 
 
 
 
 
 

Office of Clinical Site Oversight (OCSO)

​​

Last Updated August 24, 2015